News & Events

News &

Tarsier Pharma Will Participate At The H.C. Wainwright Bioconnect Conference

January 10-13, 2022

Dr. Daphne Haim-Langford, Tarsier Pharma’s CEO and Chairperson, will hold a fireside chat at the H.C. Wainwright Bioconnect Conference, and be available for 1X1 meetings with investors.

Registration is open here, investors interested to meet are welcome to contact their H.C. Wainwright representative.

Scroll to Top